Flu Cases Surge Across U.S. as New Variant Drives Rapid Spread

Flu infections are spiking dramatically across the United States, with a new variant called “subclade K” fueling the rise as Americans continue holiday travels and gatherings. According to the Centers for Disease Control and Prevention (CDC), more than half the states are now reporting high or very high levels of influenza-like illness.

The CDC estimates at least 7.5 million Americans have contracted the flu so far this season, resulting in approximately 81,000 hospitalizations and 3,100 deaths, including at least eight children. These figures, based on data through December 20, precede the major holiday gathering season when transmission typically accelerates.

New York has been particularly hard hit, with state health officials reporting 71,000 flu cases during the week ending December 20—the highest weekly total the state has recorded since 2004.

The subclade K variant driving this season’s outbreak has already caused significant early outbreaks in the United Kingdom, Japan, and Canada. While flu season typically begins its winter spread in December in the United States, the rapid rise of this particular variant has health officials concerned about its trajectory.

“This variant belongs to the H3N2 strain, which typically causes more severe seasons, especially for older adults,” explains Andrew Pekosz, a virus expert at Johns Hopkins Bloomberg School of Public Health. “The mutations in subclade K aren’t enough to make it an entirely new kind of flu, but they’re significant enough to potentially evade some protection from this year’s vaccine.”

Despite concerns about vaccine effectiveness against this variant, health officials emphasize it’s not too late to get a flu shot. While this year’s vaccine may not perfectly match the subclade K strain, preliminary analysis from the United Kingdom indicates it still offers meaningful protection, particularly against severe illness requiring hospitalization.

“Even partial protection significantly lowers people’s risk of hospitalization,” Pekosz noted. “And the vaccine appears to be a good match against H1N1 and Type B influenza strains that may also circulate this season.”

CDC data shows only about 42% of adults and children have received their flu vaccination so far this season, leaving a significant portion of the population vulnerable as cases rise.

Health experts are still working to determine whether subclade K simply spreads more efficiently or if it also causes more severe illness. Flu seasons dominated by H3N2 variants generally result in more infections and serious illnesses, but it will take time for researchers to establish the full clinical profile of this particular subclade.

For those who do contract the flu, prescription antiviral medications can help reduce symptoms and complications, but they typically need to be started within one or two days after symptoms begin. These treatments are especially important for high-risk individuals, including seniors, pregnant women, young children, and those with chronic health conditions.

The CDC continues to recommend flu vaccination for nearly everyone six months and older, despite recent misinformation about vaccines circulating on social media. Flu remains particularly dangerous for people over 65, pregnant women, young children, and those with chronic health problems such as asthma, diabetes, heart disease, and compromised immune systems.

Several vaccination options are available this season, including traditional shots for all age groups and the nasal spray FluMist for those aged 2 to 49. In a first for the U.S., some eligible individuals may now have the option to self-administer FluMist at home, potentially increasing accessibility.

As the holiday season continues, public health officials urge Americans to take precautions, including vaccination, frequent handwashing, covering coughs and sneezes, and staying home when ill to help slow the rapid spread of this flu variant.